These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6466864)

  • 1. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation].
    Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR
    Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetogenic action of alloxan in short-term termination of the blood supply to the pancreas and spleen].
    Ul'ianov AM; Tarasov IuA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (8):48-51. PubMed ID: 6487685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative evaluation of the sensitivity of experimental animals to the diabetogenic effect of alloxan].
    Pal'chikova NA; Seliatitskaia VG; Shorin IuP
    Probl Endokrinol (Mosk); 1987; 33(4):65-8. PubMed ID: 3658953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats.
    Moustafa SA
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):149-55. PubMed ID: 15541754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of an increased protein and fat content in the food ration of rats for the development of stable alloxan diabetes].
    Ul'ianov AM; Tarasov IuA
    Probl Endokrinol (Mosk); 1989; 35(6):78-81. PubMed ID: 2622891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes.
    Buko V; Lukivskaya O; Nikitin V; Tarasov Y; Zavodnik L; Borodinsky A; Gorenshtein B; Janz B; Gundermann KJ; Schumacher R
    Cell Biochem Funct; 1996 Jun; 14(2):131-7. PubMed ID: 8640953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes].
    Kudriashov BA; Ul'ianov AM
    Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tilapia islet grafts are highly alloxan-resistant.
    Xu BY; Morrison CM; Yang H; Wright JR
    Gen Comp Endocrinol; 2004 Jun; 137(2):132-40. PubMed ID: 15158125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decreased sensitivity to the hypoglycemic action of insulin in animals with a lowered blood heparin concentration].
    Ul'ianov AM; Shapiro FB; Bazaz'ian GG
    Biull Eksp Biol Med; 1987 May; 103(5):522-4. PubMed ID: 3297185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetogenic action of alloxan following temporary interruption of arterial blood flow to pancreas in rats.
    Bilic N; Felber JP
    Diabetes; 1970 Feb; 19(2):81-4. PubMed ID: 4905638
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental diabetes in mice infected with Coxsackie viruses].
    Bocharov EF; Shorin IuP; Solodovnikova IA; Kazarian LS; Seliatitskaia VG
    Biull Eksp Biol Med; 1987 Feb; 103(2):163-6. PubMed ID: 3028528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of alloxan diabetes in duct-ligated rats. A functional and morphological study.
    Edström C
    Acta Pathol Microbiol Scand A; 1973 Jan; 81(1):21-35. PubMed ID: 4569531
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of dopaminergic pharmacological agents on the pancreatic islet apparatus in rats].
    Boiadzhieva N
    Eksp Med Morfol; 1990; 29(3):20-6. PubMed ID: 1980459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of the diabetogenic effects of alloxan in rats in deep hypothermia].
    Levet E; Cier A; Girod C
    C R Seances Soc Biol Fil; 1970; 164(11):2298-301. PubMed ID: 4257362
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes evolution in rats after neonatal treatment with alloxan.
    Ribeiro C; de Oliveira CA; Luciano E; de Mello MA
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():29-46. PubMed ID: 18426077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudocholinesterase in alloxan-diabetic rats.
    Oresković K; Kunec-Vajić E
    Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):117-20. PubMed ID: 1462046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of exercise on long-term effects of alloxan administered in neonatal rats.
    de Oliveira CA; Luciano E; de Mello MA
    Exp Physiol; 2005 Jan; 90(1):79-86. PubMed ID: 15466460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats.
    Méndez JD; Hernández Rde H
    Biomed Pharmacother; 2005 Jul; 59(6):283-9. PubMed ID: 15996850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.